Baker Bros. Advisors as of March 31, 2019
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 96 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 23.9 | $3.7B | 51M | 73.24 | |
| Incyte Corporation (INCY) | 18.9 | $2.9B | 34M | 86.01 | |
| Beigene (BGNE) | 10.1 | $1.6B | 12M | 132.00 | |
| Alexion Pharmaceuticals | 7.4 | $1.2B | 8.6M | 135.18 | |
| ACADIA Pharmaceuticals (ACAD) | 6.8 | $1.1B | 40M | 26.85 | |
| Amarin Corporation (AMRN) | 5.7 | $897M | 43M | 20.76 | |
| Genomic Health | 4.6 | $714M | 10M | 70.05 | |
| BioMarin Pharmaceutical (BMRN) | 4.3 | $674M | 7.6M | 88.83 | |
| Ascendis Pharma A S (ASND) | 2.5 | $399M | 3.4M | 117.70 | |
| Mirati Therapeutics | 1.2 | $184M | 2.5M | 73.30 | |
| Madrigal Pharmaceuticals (MDGL) | 0.9 | $147M | 1.2M | 125.26 | |
| Argenx Se (ARGX) | 0.8 | $127M | 1.0M | 124.84 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $123M | 15M | 8.14 | |
| Heron Therapeutics (HRTX) | 0.8 | $123M | 5.0M | 24.44 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $97M | 1.1M | 88.10 | |
| Clementia | 0.6 | $97M | 3.7M | 26.10 | |
| Array BioPharma | 0.6 | $94M | 3.8M | 24.38 | |
| Invitae (NVTAQ) | 0.6 | $91M | 3.9M | 23.42 | |
| Spark Therapeutics | 0.6 | $86M | 752k | 113.88 | |
| Cymabay Therapeutics | 0.5 | $76M | 5.7M | 13.28 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $74M | 2.7M | 27.41 | |
| Gw Pharmaceuticals Plc ads | 0.5 | $72M | 428k | 168.57 | |
| Neurocrine Biosciences Inc Note 2.250 5/1 | 0.5 | $72M | 53M | 1.35 | |
| Tricida | 0.5 | $70M | 1.8M | 38.62 | |
| Cerus Corporation (CERS) | 0.4 | $67M | 11M | 6.23 | |
| Audentes Therapeutics | 0.4 | $67M | 1.7M | 39.02 | |
| Insmed (INSM) | 0.4 | $60M | 2.1M | 29.07 | |
| Principia Biopharma | 0.4 | $61M | 1.8M | 34.00 | |
| Kodiak Sciences (KOD) | 0.4 | $60M | 9.1M | 6.53 | |
| Kiniksa Pharmaceuticals | 0.3 | $54M | 3.0M | 18.06 | |
| Myokardia | 0.3 | $53M | 1.0M | 51.99 | |
| Dbv Technologies S A | 0.3 | $43M | 5.5M | 7.71 | |
| Uniqure Nv (QURE) | 0.2 | $36M | 605k | 59.65 | |
| Aquinox Pharmaceuticals | 0.2 | $30M | 11M | 2.70 | |
| Zymeworks | 0.2 | $28M | 1.7M | 16.18 | |
| Krystal Biotech (KRYS) | 0.2 | $26M | 785k | 32.90 | |
| Ra Pharmaceuticals | 0.1 | $18M | 823k | 22.40 | |
| Axsome Therapeutics (AXSM) | 0.1 | $17M | 1.2M | 14.23 | |
| Merus N V (MRUS) | 0.1 | $17M | 1.2M | 14.77 | |
| Aimmune Therapeutics | 0.1 | $15M | 674k | 22.35 | |
| Biomarin Pharma Inc convertible/ | 0.1 | $16M | 15M | 1.03 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $15M | 2.9M | 5.10 | |
| Xencor (XNCR) | 0.1 | $13M | 428k | 31.06 | |
| Aeglea Biotherapeutics | 0.1 | $14M | 1.7M | 8.05 | |
| Dermira | 0.1 | $12M | 907k | 13.55 | |
| Idera Pharmaceuticals | 0.1 | $12M | 4.8M | 2.55 | |
| Sangamo Biosciences (SGMO) | 0.1 | $9.5M | 1000k | 9.54 | |
| Bellicum Pharma | 0.1 | $9.0M | 2.7M | 3.37 | |
| Abeona Therapeutics | 0.1 | $9.5M | 1.3M | 7.36 | |
| Marker Therapeutics Ord | 0.1 | $9.9M | 1.5M | 6.60 | |
| Albireo Pharma | 0.1 | $8.1M | 250k | 32.21 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $8.3M | 113k | 73.05 | |
| Bluebird Bio (BLUE) | 0.0 | $6.3M | 40k | 157.32 | |
| Spring Bk Pharmaceuticals In | 0.0 | $6.4M | 613k | 10.49 | |
| Apellis Pharmaceuticals (APLS) | 0.0 | $6.1M | 314k | 19.50 | |
| Inflarx Nv (IFRX) | 0.0 | $6.8M | 179k | 37.79 | |
| Menlo Therapeutics | 0.0 | $5.5M | 700k | 7.85 | |
| Halozyme Therapeutics (HALO) | 0.0 | $4.8M | 300k | 16.10 | |
| Acceleron Pharma | 0.0 | $3.9M | 84k | 46.57 | |
| Macrogenics (MGNX) | 0.0 | $5.4M | 303k | 17.98 | |
| Viking Therapeutics (VKTX) | 0.0 | $4.2M | 425k | 9.94 | |
| Syros Pharmaceuticals | 0.0 | $5.3M | 575k | 9.14 | |
| Protagonist Therapeutics (PTGX) | 0.0 | $5.1M | 404k | 12.57 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.0 | $4.9M | 157k | 31.47 | |
| Forty Seven | 0.0 | $4.0M | 250k | 16.16 | |
| Acorda Therapeutics | 0.0 | $3.9M | 292k | 13.29 | |
| Achillion Pharmaceuticals | 0.0 | $3.2M | 1.1M | 2.96 | |
| Alkermes (ALKS) | 0.0 | $2.4M | 67k | 36.49 | |
| Chemocentryx | 0.0 | $2.9M | 207k | 13.89 | |
| La Jolla Pharmaceuticl Com Par | 0.0 | $3.2M | 505k | 6.43 | |
| Assembly Biosciences | 0.0 | $2.9M | 149k | 19.69 | |
| Galapagos Nv- (GLPG) | 0.0 | $3.0M | 25k | 117.78 | |
| Sierra Oncology | 0.0 | $3.4M | 2.0M | 1.71 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.0 | $3.0M | 131k | 22.76 | |
| Y Mabs Therapeutics (YMAB) | 0.0 | $2.7M | 103k | 26.21 | |
| Aravive | 0.0 | $3.0M | 431k | 7.04 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $1.1M | 580k | 1.88 | |
| Galmed Pharmaceuticals | 0.0 | $1.8M | 216k | 8.17 | |
| Adamas Pharmaceuticals | 0.0 | $1.2M | 173k | 7.11 | |
| Foamix Pharmaceuticals | 0.0 | $1.9M | 498k | 3.75 | |
| Affimed Therapeutics B V | 0.0 | $840k | 200k | 4.20 | |
| Contrafect | 0.0 | $1.2M | 2.9M | 0.40 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $2.1M | 194k | 10.75 | |
| Intellia Therapeutics (NTLA) | 0.0 | $2.2M | 129k | 17.08 | |
| G1 Therapeutics | 0.0 | $2.1M | 127k | 16.60 | |
| Molecular Templates | 0.0 | $1.5M | 254k | 5.81 | |
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.5M | 122k | 12.49 | |
| Constellation Pharmceticls I | 0.0 | $1.8M | 133k | 13.55 | |
| Orchard Therapeutics Plc ads | 0.0 | $2.2M | 125k | 17.88 | |
| Harpoon Therapeutics | 0.0 | $2.0M | 214k | 9.47 | |
| Dynavax Technologies (DVAX) | 0.0 | $548k | 75k | 7.31 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $334k | 505k | 0.66 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $674k | 557k | 1.21 | |
| Fulgent Genetics (FLGT) | 0.0 | $744k | 125k | 5.95 | |
| Ritter Pharmaceuticals | 0.0 | $244k | 280k | 0.87 | |
| Aquestive Therapeutics (AQST) | 0.0 | $688k | 100k | 6.91 |
